Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-22-026643
Filing Date
2022-10-19
Accepted
2022-10-19 17:24:44
Documents
4
Effectiveness Date
2022-10-19

Document Format Files

Seq Description Document Type Size
1 S-8 primemedicine-sx8.htm S-8 71369
2 EX-FILING FEES exhibit107-sx8.htm EX-FILING FEES 26224
3 EX-5.1 exhibit51-sx8.htm EX-5.1 6495
4 EX-23.1 exhibit231-sx8.htm EX-23.1 2869
  Complete submission text file 0001628280-22-026643.txt   107924
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-267953 | Film No.: 221319289
SIC: 2836 Biological Products, (No Diagnostic Substances)